135 related articles for article (PubMed ID: 10697753)
1. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release.
Faham A; Prinderre P; Farah N; Eichler KD; Kalantzis G; Joachim J
Drug Dev Ind Pharm; 2000 Feb; 26(2):167-76. PubMed ID: 10697753
[TBL] [Abstract][Full Text] [Related]
2. Hot melt coating technology: influence of Compritol 888 Ato and granule size on chloroquine release.
Faham A; Prinderre P; Piccerelle P; Farah N; Joachim J
Pharmazie; 2000 Jun; 55(6):444-8. PubMed ID: 10907253
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
[TBL] [Abstract][Full Text] [Related]
4. Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate).
Zhang F; McGinity JW
Drug Dev Ind Pharm; 2000 Sep; 26(9):931-42. PubMed ID: 10914317
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
6. Theophylline-loaded compritol microspheres prepared by ultrasound-assisted atomization.
Fini A; Cavallari C; Ospitali F; Gonzalez-Rodriguez ML
J Pharm Sci; 2011 Feb; 100(2):743-57. PubMed ID: 20815082
[TBL] [Abstract][Full Text] [Related]
7. Application of fibroin in controlled release tablets containing theophylline.
Katayama H; Issiki M; Yoshitomi H
Biol Pharm Bull; 2000 Oct; 23(10):1229-34. PubMed ID: 11041257
[TBL] [Abstract][Full Text] [Related]
8. Tableting of hot-melt coated paracetamol granules: Material tableting properties and quality characteristics of the obtained tablets.
Milanovic A; Aleksic I; Ibric S; Parojcic J; Cvijic S
Eur J Pharm Sci; 2020 Jan; 142():105121. PubMed ID: 31669762
[TBL] [Abstract][Full Text] [Related]
9. Compritol 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulations.
Barthelemy P; Laforêt JP; Farah N; Joachim J
Eur J Pharm Biopharm; 1999 Jan; 47(1):87-90. PubMed ID: 10234531
[TBL] [Abstract][Full Text] [Related]
10. In vitro conditions for the study of the in vivo performance of sustained-release theophylline matrix tablets administered in fasted conditions and with a high-fat diet.
Andonaegui MT; Barría JL; Thielemann AM; Seitz C; Gai MN
Drug Dev Ind Pharm; 1999 Nov; 25(11):1199-203. PubMed ID: 10596358
[TBL] [Abstract][Full Text] [Related]
11. Multi-unit dosage formulations of theophylline for controlled release applications.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2007; 64(6):553-9. PubMed ID: 18323251
[TBL] [Abstract][Full Text] [Related]
12. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.
Bayomi MA; Al-Suwayeh SA; El-Helw AR
Drug Dev Ind Pharm; 2001 Jul; 27(6):499-506. PubMed ID: 11548856
[TBL] [Abstract][Full Text] [Related]
13. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
Alsarra IA; El-Bagory I; Bayomi MA
Drug Dev Ind Pharm; 2005 May; 31(4-5):385-95. PubMed ID: 16093204
[TBL] [Abstract][Full Text] [Related]
14. Melt granulation and heat treatment for wax matrix-controlled drug release.
Zhang YE; Schwartz JB
Drug Dev Ind Pharm; 2003 Feb; 29(2):131-8. PubMed ID: 12648009
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
[TBL] [Abstract][Full Text] [Related]
16. Optimizing a wet granulation process to obtain high-dose sustained-release tablets with Compritol 888 ATO.
Rosiaux Y; Girard JM; Desvignes F; Miolane C; Marchaud D
Drug Dev Ind Pharm; 2015; 41(10):1738-44. PubMed ID: 25652358
[TBL] [Abstract][Full Text] [Related]
17. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine.
Cantor SL; Hoag SW; Augsburger LL
Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
20. A new drug delivery system using plasma-irradiated pharmaceutical aids. V. Controlled release of theophylline from plasma-irradiated double-compressed tablet composed of a wall material containing polybenzylmethacrylate.
Ishikawa M; Noguchi T; Niwa J; Kuzuya M
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2215-20. PubMed ID: 8582024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
